Cardiff International (OTCQB:CDIF) said today that it has agreed to acquire MedicaMetrix as a subsidiary in an all-stock transaction valued at $6 million. Delaware-based MedicaMetrix has developed a medical device, ProstaMetric, that enables more effective prostate cancer diagnosis and monitoring. The device won CE Mark clearance in the European Union in October last year and has […]